| Product Code: ETC7613685 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iraq Neurodegenerative Disease Market Overview |
3.1 Iraq Country Macro Economic Indicators |
3.2 Iraq Neurodegenerative Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Iraq Neurodegenerative Disease Market - Industry Life Cycle |
3.4 Iraq Neurodegenerative Disease Market - Porter's Five Forces |
3.5 Iraq Neurodegenerative Disease Market Revenues & Volume Share, By Indication Type, 2021 & 2031F |
3.6 Iraq Neurodegenerative Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 Iraq Neurodegenerative Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of neurodegenerative diseases in Iraq |
4.2.2 Growing elderly population in Iraq leading to higher incidence of neurodegenerative diseases |
4.2.3 Advancements in medical technology and treatment options for neurodegenerative diseases |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services and treatments in certain regions of Iraq |
4.3.2 Socioeconomic factors affecting affordability of neurodegenerative disease treatments |
4.3.3 Lack of healthcare infrastructure and resources in Iraq |
5 Iraq Neurodegenerative Disease Market Trends |
6 Iraq Neurodegenerative Disease Market, By Types |
6.1 Iraq Neurodegenerative Disease Market, By Indication Type |
6.1.1 Overview and Analysis |
6.1.2 Iraq Neurodegenerative Disease Market Revenues & Volume, By Indication Type, 2021- 2031F |
6.1.3 Iraq Neurodegenerative Disease Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.1.4 Iraq Neurodegenerative Disease Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.1.5 Iraq Neurodegenerative Disease Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.6 Iraq Neurodegenerative Disease Market Revenues & Volume, By Huntington Disease, 2021- 2031F |
6.1.7 Iraq Neurodegenerative Disease Market Revenues & Volume, By Other Indication Types, 2021- 2031F |
6.2 Iraq Neurodegenerative Disease Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Iraq Neurodegenerative Disease Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 Iraq Neurodegenerative Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.4 Iraq Neurodegenerative Disease Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F |
6.2.5 Iraq Neurodegenerative Disease Market Revenues & Volume, By Immunomodulatory Drugs, 2021- 2031F |
6.2.6 Iraq Neurodegenerative Disease Market Revenues & Volume, By Other Drug Types, 2021- 2031F |
7 Iraq Neurodegenerative Disease Market Import-Export Trade Statistics |
7.1 Iraq Neurodegenerative Disease Market Export to Major Countries |
7.2 Iraq Neurodegenerative Disease Market Imports from Major Countries |
8 Iraq Neurodegenerative Disease Market Key Performance Indicators |
8.1 Number of neurologists and specialists per capita in Iraq |
8.2 Percentage of the population covered by health insurance in Iraq |
8.3 Government expenditure on healthcare as a percentage of GDP in Iraq |
9 Iraq Neurodegenerative Disease Market - Opportunity Assessment |
9.1 Iraq Neurodegenerative Disease Market Opportunity Assessment, By Indication Type, 2021 & 2031F |
9.2 Iraq Neurodegenerative Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 Iraq Neurodegenerative Disease Market - Competitive Landscape |
10.1 Iraq Neurodegenerative Disease Market Revenue Share, By Companies, 2024 |
10.2 Iraq Neurodegenerative Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here